When survival of HPV+ HNSCC patients with low expression of both COX16 and COX17 in their tumours was compared to survival of patients with high expression of both genes, survival was significantly greater in the COX16 and COX17 double low expression group (p = 0.0015) (Figure 5A). The gene discussed is COX16; the disease is head and neck squamous cell carcinoma.